Bio Protocol vs Epic Chain — how do they compare? Bio Protocol trades at Rp439.16 (market cap Rp1T, Rp172,7M 24h volume), while Epic Chain trades at Rp6,030 (market cap Rp199,59M, Rp198,9M 24h volume). The key difference: Bio Protocol is far larger — about 5010.3× Epic Chain's market cap, and Bio Protocol's circulating supply is 2,3B / 3,3B BIO (69%) versus 33,6M / 33,6M EPIC (100%) for Epic Chain. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 17 Days and Epic Chain for 9 Days on average.
| BIO | EPIC | |
|---|---|---|
Market Cap | Rp1T | Rp199,59M |
Volume (24h) | Rp172,7M | Rp198,9M |
Circulating Supply | 2,3B / 3,3B BIO (69%) | 33,6M / 33,6M EPIC (100%) |
Typical Hold Time | 17 Days | 9 Days |
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp424.33 with a market cap of Rp965.85M, showing neutral technical signals amid bearish moving averages. The token's circulating supply of 2.3M out of 3.3M max indicates 69% circulation with an average hold time of 17 days. Recent technical indicators show mixed signals with RSI in neutral territory while ADX suggests some buying momentum. Support and resistance levels are well-defined between Rp398 and Rp500.
Overall outlook remains neutral with key opportunities in protocol adoption growth, though risks include limited liquidity and typical crypto volatility. Investors should monitor network activity closely as the token operates in a competitive blockchain ecosystem without major recent protocol updates.
Epic Chain is trading at Rp6,217, exhibiting a bearish technical outlook with strong selling pressure in moving averages. The token is fully distributed with a market cap of Rp209.23 million. Current price is near support at Rp5,832, while RSI_6 at 23.56 indicates potential oversold conditions. No recent protocol updates or ecosystem news are available.
Overall outlook remains cautious due to bearish momentum and limited liquidity. Key opportunity lies in oversold RSI signaling possible short-term bounce. Major risks include low market cap volatility, absence of recent developments, and thin trading volumes exacerbating price swings.
What Pluang investors did over the last 30 days
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →Epic Chain (EPIC), the successor to Ethernity Chain (ERN), was approved by 97.1% of the community and now operates as an ETH Layer 2 blockchain. Focused on Real World Assets (RWAs) and entertainment, it integrates AI-driven security, DRM, and Web3 technology. With the entertainment market set to hit $3.5 trillion by 2030, Epic Chain enables global brands to bring franchises on-chain, already featuring icons like Messi, Shaq, and Muhammad Ali. Now, it expands into top entertainment franchises with improved scalability, security, and efficiency.
Read more on EPIC →